AAV therapies by convection enhanced delivery (CED): What to expect from non-clinical safety studies

被引：0
|
作者：
Vats, Srishti [1 ]
Bouchard, Amelie [1 ]
Foret, Morgan [1 ]
Maghezzi, Said [1 ]
Galicia, Archival [1 ]
Bennamoune, Nehla [1 ]
Authier, Simon [1 ]
机构：
[1] Charles River Labs, Laval, PQ, Canada
来源：
JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS | 2023年 / 123卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
SP028
引用
收藏
页数：2
相关论文
共 50 条
  • [1] DEFORMATIONAL CHANGES IN THE HUMAN BRAIN STEM FROM CONVECTION ENHANCED DELIVERY (CED)
    Tizi, Karima
    Wembacher, Eva
    Thomson, Rowena
    Donzelli, Maria
    Vaconcellos, Elizabeth
    Souweidane, Mark
    NEURO-ONCOLOGY, 2016, 18 : 72 - 72
  • [2] What Are Our Options for CNS Delivery of AAV Therapies: Systemic, Intrathecal, Intracerebroventricular,Convection-Enhanced Delivery, or MRI-Guided Focused Ultrasound?
    Hoberman, Alan
    Maghezzi, Said
    Foret, Morgan
    Wong, Karen
    Para, Camila
    Vats, Srishti
    Authier, Simon
    Li, Christian
    Noroozian, Zeinab
    Ruppert, Michael
    INTERNATIONAL JOURNAL OF TOXICOLOGY, 2024, 43 (01) : 114 - 115
  • [3] Opportunities for in vivo imaging in non-clinical safety studies
    Stephan-Gueldner, M.
    Buergin, H.
    Funk, J.
    Grimm, H. P.
    Sanders, M.
    Zabka, T. S.
    Singer, T.
    Bergstroem, M.
    TOXICOLOGY LETTERS, 2011, 205 : S24 - S24
  • [4] Non-Viral Gene Therapy for Brain Tumors via Convection Enhanced Delivery (CED)
    Negron, Karina
    MOLECULAR THERAPY, 2018, 26 (05) : 419 - 420
  • [5] Widespread optogenetic expression in macaque cortex obtained with MR-guided, convection enhanced delivery (CED) of AAV vector to the thalamus
    Yazdan-Shahmorad, Azadeh
    Tian, Nan
    Kharazia, Viktor
    Samaranch, Lluis
    Kells, Adrian
    Bringas, John
    He, Jiwei
    Bankiewicz, Krystof
    Sabes, Philip N.
    JOURNAL OF NEUROSCIENCE METHODS, 2018, 293 : 347 - 358
  • [6] Non-clinical safety evaluation of AAV5-PBGD in mice and cynomolgus macaques
    Gonzalez-Aseguinolaza, Gloria
    Paneda, Astrid
    Lopez-Franco, Esperanza
    Olaguee, Cristina
    Fontanellas, Antonio
    Unzu, Carmen
    Sampedro, Ana
    Eugenia Cornet, Maria
    del Mar Municio, Maria
    Heal, Paul
    Petry, Harald
    Sonnemans, Marc
    Spronck, Lisa
    Salmon, Florence
    TOXICOLOGY LETTERS, 2013, 221 : S59 - S59
  • [7] Non-clinical safety evaluation of AAV5-PBGD in mice and cynomolgus macaques
    Gonzalez-Aseguinolaza, Gloria
    Paneda Rodriguez, Astrid
    Lopez-Franco, Esperanza
    Olaguee, Cristina
    Fontanellas, Antonio
    Unzu, Carmen
    Sampedro, Ana
    Eugenia Cornet, Maria
    del Mar Municio, Maria
    Heal, Paul
    Petry, Harald
    Sonnemans, Marc
    Nijmeier, Bart
    Salmon, Florence
    HUMAN GENE THERAPY, 2012, 23 (10) : A150 - A150
  • [8] Non-clinical safety studies on biosimilar recombinant human erythropoietin
    Parnham, Michael J.
    Schindler-Horvat, Janice
    Kozlovic, Marija
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2007, 100 (02) : 73 - 83
  • [9] Considerations for non-clinical safety studies of therapeutic peptide vaccines
    Matsumoto, Mineo
    Komatsu, Shinichi
    Tsuchimoto, Mayumi
    Matsui, Hajime
    Watanabe, Kazuto
    Nakamura, Kazuichi
    Amakasu, Kohei
    Ito, Kanako
    Fueki, Osamu
    Sawada, Jun-ichi
    Maki, Kazushige
    Onodera, Hiroshi
    REGULATORY TOXICOLOGY AND PHARMACOLOGY, 2014, 70 (01) : 254 - 260
  • [10] Selection of appropriate non-clinical animal models to ensure translatability of novel AAV-gene therapies to the clinic
    Mark Singh
    Andrew Brooks
    Parto Toofan
    Keith McLuckie
    Gene Therapy, 2024, 31 : 56 - 63
12345